Download PDF
Semin intervent Radiol 2014; 31(02): 118-124
DOI: 10.1055/s-0034-1373786
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Thermal Ablation of Stage I Non-Small Cell Lung Carcinoma

Carol A. Ridge
1   Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland
,
Stephen B. Solomon
2   Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
,
Raymond H. Thornton
2   Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
21 May 2014 (online)

Also available at
    Permissions and Reprints

Abstract

Ablation options for the treatment of localized non-small cell lung carcinoma (NSCLC) include radiofrequency ablation, microwave ablation, and cryotherapy. Irreversible electroporation is a novel ablation method with the potential of application to lung tumors in risky locations. This review article describes the established and novel ablation techniques used in the treatment of localized NSCLC, including mechanism of action, indications, potential complications, clinical outcomes, postablation surveillance, and use in combination with other therapies.

Keywords

ablation techniques - carcinoma - non-small cell lung - tomography - x-ray computed - positron emission tomography - radiology - interventional radiology
 

  • References

  • 1 McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25 (3) 267-270
    CrossrefPubMedGoogle Scholar
  • 2 Rossi S, Fornari F, Pathies C, Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 1990; 76 (1) 54-57
    CrossrefPubMedGoogle Scholar
  • 3 Buscarini L, Rossi S, Fornari F, Di Stasi M, Buscarini E. Laparoscopic ablation of liver adenoma by radiofrequency electrocauthery. Gastrointest Endosc 1995; 41 (1) 68-70
    CrossrefPubMedGoogle Scholar
  • 4 Fraker DL. Percutaneous radiofrequency interstitial thermal ablation. Cancer J Sci Am 1995; 1 (1) 30-31
    PubMedGoogle Scholar
  • 5 Goldberg SN, Gazelle GS, Compton CC, McLoud TC. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 1995; 2 (9) 776-784
    CrossrefPubMedGoogle Scholar
  • 6 Goldberg SN, Gazelle GS, Compton CC, Mueller PR, McLoud TC. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol 1996; 3 (11) 929-935
    CrossrefPubMedGoogle Scholar
  • 7 Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174 (1) 57-59
    CrossrefPubMedGoogle Scholar
  • 8 Yu H, Burke C. Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors. Semin Intervent Radiol 2014; 31 (2) 129-137
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Zivin S, Gaba R. Technical and practical consideration for device selection in locoregional ablative therapy. Semin Intervent Radiol 2014; 31 (2) 212-224
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S179-S186
    CrossrefPubMedGoogle Scholar
  • 11 Lubner MG, Brace CL, Hinshaw JL, Lee Jr FT. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S192-S203
    CrossrefPubMedGoogle Scholar
  • 12 Erinjeri JP, Clark TW. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S187-S191
    CrossrefPubMedGoogle Scholar
  • 13 Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174 (2) 323-331
    CrossrefPubMedGoogle Scholar
  • 14 Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10 (6) 787-800
    CrossrefPubMedGoogle Scholar
  • 15 Cosman ER, Nashold BS, Ovelman-Levitt J. Theoretical aspects of radiofrequency lesions in the dorsal root entry zone. Neurosurgery 1984; 15 (6) 945-950
    CrossrefPubMedGoogle Scholar
  • 16 Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1995; 2 (5) 399-404
    CrossrefPubMedGoogle Scholar
  • 17 Ahmed M, Brace CL, Lee Jr FT, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology 2011; 258 (2) 351-369
    CrossrefPubMedGoogle Scholar
  • 18 O'Rourke AP, Haemmerich D, Prakash P, Converse MC, Mahvi DM, Webster JG. Current status of liver tumor ablation devices. Expert Rev Med Devices 2007; 4 (4) 523-537
    CrossrefPubMedGoogle Scholar
  • 19 Sharma A, Moore WH, Lanuti M, Shepard JA. How I do it: radiofrequency ablation and cryoablation of lung tumors. J Thorac Imaging 2011; 26 (2) 162-174
    CrossrefPubMedGoogle Scholar
  • 20 Ahrar K, Littrup PJ. Is cryotherapy the optimal technology for ablation of lung tumors?. J Vasc Interv Radiol 2012; 23 (3) 303-305
    CrossrefPubMedGoogle Scholar
  • 21 Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 2007; 6 (1) 37-48
    CrossrefPubMedGoogle Scholar
  • 22 Lee EW, Loh CT, Kee ST. Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 2007; 6 (4) 287-294
    CrossrefPubMedGoogle Scholar
  • 23 Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences?. Curr Probl Diagn Radiol 2009; 38 (3) 135-143
    CrossrefPubMedGoogle Scholar
  • 24 Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37 (3) 171-186
    CrossrefPubMedGoogle Scholar
  • 25 Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol 2002; 178 (1) 47-51
    CrossrefPubMedGoogle Scholar
  • 26 Gillams AR, Lees WR. Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol 2008; 18 (4) 672-677
    CrossrefPubMedGoogle Scholar
  • 27 Crocetti L, Bozzi E, Faviana P , et al. Thermal ablation of lung tissue: in vivo experimental comparison of microwave and radiofrequency. Cardiovasc Intervent Radiol 2010; 33 (4) 818-827
    CrossrefPubMedGoogle Scholar
  • 28 Weber SM, Lee Jr FT, Chinn DO, Warner T, Chosy SG, Mahvi DM. Perivascular and intralesional tissue necrosis after hepatic cryoablation: results in a porcine model. Surgery 1997; 122 (4) 742-747
    CrossrefPubMedGoogle Scholar
  • 29 Hinshaw JL, Lee Jr FT, Laeseke PF, Sampson LA, Brace C. Temperature isotherms during pulmonary cryoablation and their correlation with the zone of ablation. J Vasc Interv Radiol 2010; 21 (9) 1424-1428
    CrossrefPubMedGoogle Scholar
  • 30 Bargellini I, Bozzi E, Cioni R, Parentini B, Bartolozzi C. Radiofrequency ablation of lung tumours. Insights Imaging 2011; 2 (5) 567-576
    CrossrefPubMedGoogle Scholar
  • 31 Rose SC, Dupuy DE, Gervais DA , et al; Technology Assessment Committee of the Society of Interventional Radiology. Research reporting standards for percutaneous thermal ablation of lung neoplasms. J Vasc Interv Radiol 2009; 20 (7, Suppl): S474-S485
    CrossrefPubMedGoogle Scholar
  • 32 Pereira PL, Masala S ; Cardiovascular and Interventional Radiological Society of Europe (CIRSE). Standards of practice: guidelines for thermal ablation of primary and secondary lung tumors. Cardiovasc Intervent Radiol 2012; 35 (2) 247-254
    CrossrefPubMedGoogle Scholar
  • 33 National Institute for Health and Clinical Excellence . Available at: http://www.nice.org.uk/nicemedia/live/11206/52082/52082.pdf . Accessed September 5, 2013
    PubMed
  • 34 Ridge CA, Solomon SB. Ablation options for localized non-small cell lung cancer. In: Pass HI, Ball DB, Scagliotti GV, , eds. The IASLC Multidisciplinary Approach to Thoracic Oncology. Aurora, CO: IASLC Press; 2014. , in press
    Google Scholar
  • 35 Abbas G, Pennathur A, Landreneau RJ, Luketich JD. Radiofrequency and microwave ablation of lung tumors. J Surg Oncol 2009; 100 (8) 645-650
    CrossrefPubMedGoogle Scholar
  • 36 Schoellnast H, Deodhar A, Hsu M , et al. Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy. Acta Radiol 2012; 53 (8) 893-899
    CrossrefPubMedGoogle Scholar
  • 37 Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo T. Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 2002; 22 (Spec No) S259-S269
    CrossrefPubMedGoogle Scholar
  • 38 Alexander ES, Dupuy DE. Lung cancer ablation: technologies and techniques. Semin Intervent Radiol 2013; 30 (2) 141-150
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Carrafiello G, Mangini M, Fontana F , et al. Complications of microwave and radiofrequency lung ablation: personal experience and review of the literature. Radiol Med (Torino) 2012; 117 (2) 201-213
    CrossrefPubMedGoogle Scholar
  • 40 Palussière J, Canella M, Cornelis F , et al. Retrospective review of thoracic neural damage during lung ablation - what the interventional radiologist needs to know about neural thoracic anatomy. Cardiovasc Intervent Radiol 2013; 36 (6) 1602-1613
    CrossrefPubMedGoogle Scholar
  • 41 Alexander ES, Hankins CA, Machan JT, Healey TT, Dupuy DE. Rib fractures after percutaneous radiofrequency and microwave ablation of lung tumors: incidence and relevance. Radiology 2013; 266 (3) 971-978
    CrossrefPubMedGoogle Scholar
  • 42 Wolf FJ, Grand DJ, Machan JT, Dipetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 2008; 247 (3) 871-879
    CrossrefPubMedGoogle Scholar
  • 43 Niu L, Wang J, Zhou L , et al. Complications of cryoablation in 644 lung cancer patients and its treatment [in Chinese]. Zhongguo Fei Ai Za Zhi 2010; 13 (8) 832-834
    PubMedGoogle Scholar
  • 44 Inoue M, Nakatsuka S, Yashiro H , et al. Percutaneous cryoablation of lung tumors: feasibility and safety. J Vasc Interv Radiol 2012; 23 (3) 295-302 , quiz 305
    CrossrefPubMedGoogle Scholar
  • 45 Padda S, Kothary N, Donington J , et al. Complications of ablative therapies in lung cancer. Clin Lung Cancer 2008; 9 (2) 122-126
    CrossrefPubMedGoogle Scholar
  • 46 Yamauchi Y, Izumi Y, Hashimoto K , et al. Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer. PLoS ONE 2012; 7 (3) e33223
    CrossrefPubMedGoogle Scholar
  • 47 Belfiore G, Moggio G, Tedeschi E , et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer—a preliminary report of 33 patients. AJR Am J Roentgenol 2004; 183 (4) 1003-1011
    CrossrefPubMedGoogle Scholar
  • 48 Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010; 211 (1) 68-72
    CrossrefPubMedGoogle Scholar
  • 49 Onishi H, Araki T, Shirato H , et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004; 101 (7) 1623-1631
    CrossrefPubMedGoogle Scholar
  • 50 Ambrogi MC, Fanucchi O, Cioni R , et al. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study. J Thorac Oncol 2011; 6 (12) 2044-2051
    CrossrefPubMedGoogle Scholar
  • 51 Dupuy DE, Fernando H, Hillman S , et al. Radiofrequency ablation of stage 1A NSCLC in medically inoperable patients: results from ACOSOG Z4033 (Alliance), an NCI funded multicenter trial. Chest 2013; 144 (4_MeetingAbstracts) 86A
    CrossrefPubMedGoogle Scholar
  • 52 Pennathur A, Luketich JD, Abbas G , et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 2007; 134 (4) 857-864
    CrossrefPubMedGoogle Scholar
  • 53 Hiraki T, Gobara H, Iishi T , et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 2007; 134 (5) 1306-1312
    CrossrefPubMedGoogle Scholar
  • 54 Hsie M, Morbidini-Gaffney S, Kohman LJ, Dexter E, Scalzetti EM, Bogart JA. Definitive treatment of poor-risk patients with stage I lung cancer: a single institution experience. J Thorac Oncol 2009; 4 (1) 69-73
    CrossrefPubMedGoogle Scholar
  • 55 Lanuti M, Sharma A, Digumarthy SR , et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2009; 137 (1) 160-166
    CrossrefPubMedGoogle Scholar
  • 56 Hiraki T, Gobara H, Mimura H , et al. Radiofrequency ablation of lung cancer at Okayama University Hospital: a review of 10 years of experience. Acta Med Okayama 2011; 65 (5) 287-297
    PubMedGoogle Scholar
  • 57 Simon CJ, Dupuy DE, DiPetrillo TA , et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243 (1) 268-275
    CrossrefPubMedGoogle Scholar
  • 58 Liu H, Steinke K. High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a preliminary study. J Med Imaging Radiat Oncol 2013; 57 (4) 466-474
    CrossrefPubMedGoogle Scholar
  • 59 Palussière J, Marcet B, Descat E , et al. Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up. Cardiovasc Intervent Radiol 2011; 34 (5) 989-997
    CrossrefPubMedGoogle Scholar
  • 60 Deandreis D, Leboulleux S, Dromain C , et al. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation. Radiology 2011; 258 (1) 270-276
    CrossrefPubMedGoogle Scholar
  • 61 Yoo DC, Dupuy DE, Hillman SL , et al. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?. AJR Am J Roentgenol 2011; 197 (2) 334-340
    CrossrefPubMedGoogle Scholar
  • 62 Sharma A, Lanuti M, He W, Palmer EL, Shepard JA, Digumarthy SR. Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors. J Comput Assist Tomogr 2013; 37 (1) 9-14
    CrossrefPubMedGoogle Scholar
  • 63 Abtin FG, Eradat J, Gutierrez AJ, Lee C, Fishbein MC, Suh RD. Radiofrequency ablation of lung tumors: imaging features of the postablation zone. Radiographics 2012; 32 (4) 947-969
    CrossrefPubMedGoogle Scholar
  • 64 Crocetti L, Lencioni R. Radiofrequency ablation of pulmonary tumors. Eur J Radiol 2010; 75 (1) 23-27
    CrossrefPubMedGoogle Scholar
  • 65 Dupuy DE. Image-guided thermal ablation of lung malignancies. Radiology 2011; 260 (3) 633-655
    CrossrefPubMedGoogle Scholar
  • 66 Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 2010; 254 (1) 301-307
    PubMedGoogle Scholar
  • 67 Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 2006; 17 (7) 1117-1124
    CrossrefPubMedGoogle Scholar
  • 68 Dupuy DE, DiPetrillo T, Gandhi S , et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 2006; 129 (3) 738-745
    CrossrefPubMedGoogle Scholar
  • 69 Chan MD, Dupuy DE, Mayo-Smith WW, Ng T, DiPetrillo TA. Combined radiofrequency ablation and high-dose rate brachytherapy for early-stage non-small-cell lung cancer. Brachytherapy 2011; 10 (3) 253-259
    CrossrefPubMedGoogle Scholar